Your global partner for local literature screening

Our customers











Big database of medical and scientific literature, including local journal sites and publications from EMA, WHO, FDA, MHRA, TGA, PMDA, Swissmedic, and local Health Authorities.

Integration with MedDRA medical dictionary. E2B R2/R3 support. Easy ICSR converting to XML in accordance with international ICH requirements.

Big database of medical and scientific literature, including local journal sites and publications from EMA, WHO, FDA, MHRA, TGA, PMDA, Swissmedic, and local Health Authorities.

Compliance with FDA CFR 21 Part 11
for electronic records and signatures. Certificate of conformity allows you to use officially the system in EU, US, CIS markets.

Data centers with a certified information security management system according to ISO / IEC 27001:2013 and DigitalOcean SOC 2 Type II.

Software as a Service solution assures you will get the full access at any time on any device.
Supported by DrugCard
Medical journals coverage
Countiniously monitored
Perfomed by DrugCard

Chief Product Officer

Chief Executive Officer

Chief Product Officer

When pharma outsource PV processes to CROs, they expect the highest quality and maximum search results to ensure full compliance with regulatory requirements. CROs can no longer guarantee best results if they continue to read journals from cover to cover manually. Progressive CROs continuously discover innovative methods and tools to make their pharma customers fully compliant and satisfied.

Outsourcing of literature screening to CROs has become so widespread and common in the last 5-7 years. However, we at DrugCard strongly believe that literature screening could be done more effectively, either in-house, both global and local, or with very few contractors. Managing multiple CROs across several countries is becoming a nightmare for any MAH, creating compliance and reputation risks. DrugCard, its trusted partners, and loyal customers actively promote upgrading obsolete screening practices and help install new standards, high-performance screening methodology, and tools.

With DrugCard freelancers providing literature screening and other outsourcing services can save up to 70% of their precious time and use it for other value-adding activities such as consulting, research, quality assurance, etc. Higher productivity, less work, more revenues!
- Articles workflows
- 50 medicines
- 1 country
- 2 users
- Search report, search log
- ISO-certified data center
- CSV documentation
- 2-day reply email support

- Articles workflows
- Quality control
- Keywords highlighting
- 75 medicines
- 1 country
- 3 users
- Search report, search log
- Weekly automated report
- ISO-certified data center
- CSV documentation
- 1-day reply email support
- Articles workflows
- Quality control
- Keywords highlighting
- Safety prediction
- Article translation on demand
- 150 medicines
- 1 country
- 4 users
- Search report, search log
- Weekly automated report
- ISO-certified data center
- CSV and SOPs for implementation into an internal PV system
- 1-day reply email support
- Support on audits and inspections

"Phenomenal tool that saves time and does local literature screening instead of you. The cost is minimal in comparison to the level of results it can give."
Yes. DrugCard is fully validated and compliant according to GAMP5 and FDA CFR 21 Part 11 requirements. We ensure all cycle of continuous validation and provide reports and relevant documentation on request.
Yes. While PubMed and other large databases collect article from international journals, DrugCard performs regular weekly screening of local medical and scientific journals, published in different languages and which are not indexed in PubMed. Use DrugCard for local medical literature screening in all countries you need.
Weekly screening of every source is done. DrugCard checks if any journal updates were published on a weekly basis. If new articles were are with you search keyword, you’ll receive an automatic email notification.
Yes. The retrospective literature search can also be done as DrugCard performs screening journal archives published years ago. The exact year from which search for drug safety information varies greatly and depends on specific journal availability. It might be a few yeard or decades.
There is really no limit by country because we are covering at this moment more than 100 languages. So, we are ready to perform local literature screening on Latin, Cyrillic, and other types of alphabets (even arabic). We have customers in the CIS region (Ukraine, Kazakhstan, Azerbaidjan etc) and the EU. Also, we are covering monitoring on health authorities web sites (EMA, WHO, FDA, TGA, MHRA., etc.). So you just need to give us the list of countries or journals and we can add them to our system.
It’s not a problem. You just need to give us a list of local journals what you want to screen and we will add them to DrugCard within 2 weeks. If you don’t know exactly what it should be, our PV team will help you to create this list with relavant sources in any country.
We use DigitalOcean data centers to store and manage all the data. There are two locations of physically stored data – Amsterdam for original records and New York (US) for the backups. So, we have the ISO certificate for backup data centers and a more robust certification for original data – SOC Type 2. ISO/IEC 27001:2013 certificate.